Gastroenterology Expansion And Global Markets Will Unlock Opportunities
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
11 May 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$7.08
6.0% overvalued intrinsic discount15 Aug
US$7.51
1Y
30.8%7D
30.4%